Skip to main navigation
  • Bicycle Pharmaceuticals

Site Top Navigation

  • Publications
  • Investors & Media
    • Investor Overview
    • Press Releases
    • Investor Events and Presentations
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Contact Us
  • About
  • Approach
    • Therapies
    • Platform
    • Screening
    • Opportunity
  • Programs
  • Beyond Oncology
  • Patients
  • Careers
  • Publications
  • Investors & Media
    • Overview
    • Press Releases
    • Investor Events
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Contact Us
Events Details
  • Investor Overview
  • Press Releases
  • Investor Events and Presentations
  • SEC Filings
  • Annual General Meeting
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
  • Analyst Coverage
  • Corporate Governance
    • Documents
    • Leadership
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

IR Events

Investor Update on BT5528 and BT8009

Oct 7, 2021 at 3:00 PM EDT

Listen to Webcast

Supporting Materials

View Presentation 2.1 MB

Shareholder tools

Bicycle Therapeutics
  • Privacy Policy
  • Contact
Twitter LinkedIn Instagram
© Bicycle Therapeutics